Cogley Brian 4
4 · Coeptis Therapeutics Holdings, Inc. · Filed Jan 17, 2024
Insider Transaction Report
Form 4
Cogley Brian
Chief Financial Officer
Transactions
- Purchase
Common Stock
2024-01-10$0.67/sh+5,000$3,350→ 30,000 total
Footnotes (1)
- [F1]Includes 25,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days.